The JSE was firmer on Wednesday, with its global peers mixed as investors digest unclear important details around the Covid-19 vaccine.

The enthusiasm that followed Pfizer’s vaccine breakthrough has faded as details about its production, distribution, performance and capabilities still need to be clarified. With this in mind, investors are aware that it may take months for the vaccine to be available...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.